Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[The future of retroperitoneal lymph node dissection].

J Dubuc-Lissoir1

  • 1Département d'Obstétrique et Gynécologie, section de Gynécologie oncologique, CHUM, Hôpital Notre-Dame, Université de Montréal, 1560 rue Sherbrooke Est, Montréal, Québec, Canada H2L 4M1.

Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction
|May 11, 2000
PubMed
Summary
This summary is machine-generated.

Retroperitoneal lymph node dissection in gynecologic oncology offers minimal survival benefits but increases morbidity. Future approaches focus on prognostic value, targeted removal, and reduced complications via laparoscopic dissection and sentinel lymph node identification.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of a new energy-based vessel ligation device during laparoscopic gynecologic oncologic surgery.

Surgical endoscopy·2002
Same author

Bone metastasis from a granulosa cell tumor of the ovary.

Gynecologic oncology·2001
Same author

Phase II feasibility study of sequential couplets of Cisplatin/Topotecan followed by paclitaxel/cisplatin as primary treatment for advanced epithelial ovarian cancer: a National Cancer Institute of Canada Clinical Trials Group Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2000
Same author

Ovarian serous papillary cystadenocarcinoma stage IIIC in a 19-year-old.

Gynecologic oncology·1997
Same author

Laparoscopic staging of early ovarian cancer.

Gynecologic oncology·1995
Same author

Metastatic gestational trophoblastic disease: a comparison of prognostic classification systems.

Gynecologic oncology·1992

Area of Science:

  • Gynecologic Oncology
  • Surgical Oncology
  • Cancer Research

Context:

  • Retroperitoneal lymph node dissection (RPLND) is a standard procedure in gynecologic cancer surgery.
  • The clinical utility and necessity of RPLND are increasingly debated.
  • Recent research focuses on refining its role in cervical, ovarian, and endometrial cancers.

Purpose:

  • To re-evaluate the survival impact of RPLND in gynecologic oncology.
  • To explore methods for reducing morbidity associated with RPLND.
  • To investigate the prognostic value of lymph node dissection for future surgical strategies.

Summary:

  • RPLND has a limited impact on survival in gynecologic cancers.
  • The procedure is associated with a significant increase in patient morbidity.
  • Current research aims to identify necessary lymph nodes for removal and decrease procedural complications.

Impact:

  • Highlights the need for more precise surgical techniques in gynecologic oncology.
  • Suggests a shift towards minimally invasive approaches like laparoscopic dissection.
  • Emphasizes the importance of sentinel lymph node identification for accurate staging and treatment planning.